Last reviewed · How we verify
NCT03404011: AEPGGIBP
Acute Effects of Propylene Glycol/Glycerol Intake on Blood Parameters
NA trial testing Propylene glycol and Glycerol intake in Metabolic Complication in 24 participants. Completed in 30 December 2018.
30 December 2018
Quick facts
| Lead sponsor | Université Libre de Bruxelles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 24 |
| Start date | 15 January 2018 |
| Primary completion | 30 December 2018 |
| Estimated completion | 30 December 2018 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Propylene glycol and Glycerol intake
- Mimicking intake
Conditions studied
- Metabolic Complication — all drugs for Metabolic Complication →
Sponsor
Université Libre de Bruxelles — full company profile →
Who can join
Adults 18 to 70, any sex, with Metabolic Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the acute effect of propylene glycol and glycerol intake on cardiorespiratory blood parameters.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials.
Chaumont M, van de Borne P, Bernard A, Van Muylem A, et al · · 2019 · cited 111× · PMID 30724099 · DOI 10.1152/ajplung.00492.2018
Verify or expand the search:
- PubMed search for NCT03404011
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Complication
Currently open trials in the same condition.
- NCT03356262 — The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort · active not recruiting
Other Université Libre de Bruxelles trials
Trials by the same sponsor.
- NCT07568405 — The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold · NA · enrolling by invitation
- NCT07513974 — Objective Measurement of the Mechanical Pain Threshold With an Algometer for Predicting Intraoperative Opioid Consumptio · NA · recruiting
- NCT07236021 — e-Motion : Promoting Emotion Regulation in Chronic Cancer · NA · recruiting
- NCT06959069 — Impact of Intermittent Fasting on Sleep and Quality of Life · NA · recruiting
- NCT06666101 — Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03404011 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université Libre de Bruxelles
- Last refreshed: 17 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03404011.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing